This article first appeared on GuruFocus.

Inogen Inc (NASDAQ:INGN) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $92.20 million, and the earnings are expected to come in at -$0.22 per share. The full year 2025's revenue is expected to be $355.85 million and the earnings are expected to be -$0.97 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 3 Warning Signs with INGN.

Is INGN fairly valued? Test your thesis with our free DCF calculator.

Over the past 90 days, revenue estimates for Inogen Inc (NASDAQ:INGN) have increased from $353.70 million to $355.85 million for the full year 2025, and from $375.70 million to $387.95 million for 2026. Similarly, earnings estimates have improved from -$1.08 per share to -$0.97 per share for 2025, and from -$0.90 per share to -$0.78 per share for 2026.

In the previous quarter of 2025-06-30, Inogen Inc's (NASDAQ:INGN) actual revenue was $92.28 million, which beat analysts' revenue expectations of $90.60 million by 1.85%. Inogen Inc's (NASDAQ:INGN) actual earnings were -$0.15 per share, which beat analysts' earnings expectations of -$0.29 per share by 48.28%. After releasing the results, Inogen Inc (NASDAQ:INGN) was up by 10.39% in one day.

Based on the one-year price targets offered by 2 analysts, the average target price for Inogen Inc (NASDAQ:INGN) is $13.00 with a high estimate of $14.00 and a low estimate of $12.00. The average target implies an upside of 58.15% from the current price of $8.22.

Based on GuruFocus estimates, the estimated GF Value for Inogen Inc (NASDAQ:INGN) in one year is $9.12, suggesting an upside of 10.95% from the current price of $8.22.

Based on the consensus recommendation from 2 brokerage firms, Inogen Inc's (NASDAQ:INGN) average brokerage recommendation is currently 2.0, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.